Skip to content

Clinical trials

Observational COVID-19 trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Observational Country / region: Saudi Arabia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
202012
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King Saud University2
Qassim University2
Benha University1
Hakeam Abdulaziz Hakeam1
Imam Abdulrahman Bin Faisal University1
Johns Hopkins Aramco Healthcare1
King Faisal Specialist Hospital & Research Center1
King Khalid University1
Ministry of Health, Saudi Arabia1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1916
Anxiety Disorders2
Coronavirus Infections2
Ageusia1
Anosmia1
Asthma1
Cognitive Dysfunction1
Critical Illness1
Diabetes Complications1
Hypoglycemia1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.